Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-28T00:46:31.813Z Has data issue: false hasContentIssue false
  • English
  • Français

Success of Targeted Strategies to Reduce Methicillin-Susceptible Staphylococcus aureus Infections in the Neonatal Intensive Care Unit

Published online by Cambridge University Press:  21 March 2016

Lisa Saiman
Lisa Saiman*
Affiliation:
Columbia University Medical Center, New York, New York NewYork Presbyterian Hospital, New York, New York
*
Address correspondence and reprint requests to Lisa Saiman, MD MPH, Columbia University Medical Center, 650 West 168th Street PH 4 West Room 470, New York, NY 10032 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 4 , April 2016 , pp. 388 - 389
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Popoola, VO, Colantuoni, E, Suwantarat, N, et al. Active surveillance cultures and decolonization to reduce NICU Staphylococcus aureus infections. Infect Control Hosp Epidemiol 2016;37:381–387.CrossRefGoogle ScholarPubMed
2. Gerber, SI, Jones, RC, Scott, MV, et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006;27:139–145.CrossRefGoogle ScholarPubMed
3. Carey, AJ, Della-Latta, P, Huard, R, et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010;31:613–619.CrossRefGoogle Scholar
4. Milstone, AM, Budd, A, Shepard, JW, et al. Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study. Infect Control Hosp Epidemiol 2010;31:558–560.CrossRefGoogle Scholar
5. Graham, PL, Morel, AS, Zhou, J, et al. Epidemiology of methicillin-susceptible Staphylococcus aureus in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2002;23:677–682.CrossRefGoogle ScholarPubMed
6. Delaney, HM, Wang, E, Melish, M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2013;33:313–318.CrossRefGoogle ScholarPubMed
7. Gerber, SI, Jones, RC, Scott, MV, et al. The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000–2007. Infect Control Hosp Epidemiol 2006;27:139–145.CrossRefGoogle Scholar
8. Shane, AL, Hansen, NI, Stoll, BJ, et al. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics 2012;129:e914–e922.CrossRefGoogle ScholarPubMed
9. Stoll, BJ, Hansen, NI, Adams-Chapman, I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357–2365.CrossRefGoogle ScholarPubMed
10. Nelson, MU, Bizzarro, MJ, Debmry, LM, et al. One size does not fit all: why universal decolonization strategies to prevent methicillin-resistant Staphylococcus aureus colonization and infection in adult intensive care units may be inappropriate for neonatal intensive care units. J Perinatol 2014;34:653–655.CrossRefGoogle Scholar
11. Safety Information: 2% Chlorhexidine Gluconate (CHG) Cloth. U.S. Food and Drug Administration website. www.fda.gov/safety/medwatch/safetyinformation/safety-relateddruglabelingchanges/ucm307387.htm. Accessed January 29, 2016.Google Scholar
12. Suwantarat, N, Carroll, KC, Tekle, T, et al. High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2014;35:1183–1186.CrossRefGoogle ScholarPubMed